This was the stock's fifth consecutive day of losses.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has received a consensus rating of “Buy” from the ten ...

March 11, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio ...

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm ...

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has hit a 52-week low, trading at $5.91, down dramatically from its... Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has hit a ...

NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based ...

Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the ...

This was the stock's fourth consecutive day of losses.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...